Skip to main content
Premium Trial:

Request an Annual Quote

SuperArray Licenses RNAi IP from Carnegie Institution

NEW YORK (GenomeWeb News) – SuperArray Bioscience has licensed gene-silencing intellectual property from the Carnegie Institution, the firm said today.
 
SuperArray will use Carnegie’s technology to offer RNAi-based gene silencing products for studies including gene-specific siRNA and DNA-based RNAi expressing short hairpin RNA. It also has the right to pass on the technology to end users performing DNA-based RNA interference, said SuperArray.
 
The Frederick, Md.-based company said the agreement will allow it to generate gene-specific RNAi for every gene in the human, rat, and mouse genomes.
 
Financial terms of the agreement were not released.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.